About the Product

Empowering You to Protect the Ones You Love.

Science Lab

The Problems with Older Tests

Older methods of pathogen testing have significant drawbacks.

Clinical testing can be very expensive, results may take days or even weeks to be available, privacy is nonexistent, and the sampling process can be invasive and uncomfortable.

Old-fashioned home tests may not be as accurate as the new and improved EverTrue technology, which is also designed for more comfort at lesser expense. 

The EverTrue Answer

The EverTrue system was developed at Purdue University, in the Biomedical Engineering labs of Dr. Jacqueline Linnes PhD BME (2020 winner of the prestigious Gordon and Betty Moore Foundation Inventor Fellowship). Widely recognized as a leading Biomedical Engineer in the field of rapid pathogen testing Dr. Linnes, along with her team, designed the patented EverTrue system to address all of the problems with old style testing.

The EverTrue system uses new comfort swab technology, so it is minimally invasive. No special equipment, computers, medical staff, or far off lab is necessary. In fact you can do the test yourself, and get an easy to read answer in minutes. All for less than the price of a takeout pizza.

EverTrue helps you protect the ones you love. That’s Empowering.

About the Product

Purdue University biomedical engineers have developed a handheld paper device that quickly and accurately detects the coronavirus, even in really small quantities. A clear test result can be read directly from the device itself, making it portable.

Cost Friendly

You won’t go broke to get peace of mind.

Ease of Use

Two lines means your test is positive. One line means it’s not. 


Take the test anyplace you want. Not the doctor’s office.

Tests for Pathogen DNA

The takeaway here is that it’s more reliable. 

Rapid Results

Results in minutes. Not days. Not weeks.

Less-invasive Testing

Need we say more? 

Our Team

Dr. Jacqueline Linnes

Dr. Jacqueline Linnes is the Marta E. Gross Assistant Professor of Biomedical Engineering at Purdue University. Her work emphasizes the application of fundamental microfluidic principles and biological assays to develop point-of-care diagnostics for global health and wearable devices that enable health disparities research.


Sanjay Malkani

Sanjay actively advises Executives and drives Boards in middle market Dx and emerging tech companies. For the decade ending Q1’18, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global leader in diversified toxicology products, services and rapid diagnostics.


John Luta

For more than 20 years John Luta has been an independent finance, marketing, and human resources consultant, working with small businesses, not-for-profits, and high net worth professionals to maximize financial resources, help design product branding, and manage benefit programs to incentivize staff.